Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription

Articles published in Oncol Rep

Retrieve available abstracts of 29 articles:
HTML format

Single Articles

    February 2022
  1. GU P, Zhang M, Zhu J, He X, et al
    Suppression of CDCA3 inhibits prostate cancer progression via NFkappaB/cyclin D1 signaling inactivation and p21 accumulation.
    Oncol Rep. 2022;47.
    PubMed     Abstract available

    January 2022
  2. LIU J, Zhang Y, Li S, Sun F, et al
    Androgen deprivationinduced OPHN1 amplification promotes castrationresistant prostate cancer.
    Oncol Rep. 2022;47.
    PubMed     Abstract available

    December 2021
  3. CHEN B, Bai G, Ma X, Tan L, et al
    MicroRNA1955p is associated with cell proliferation, migration and invasion in prostate cancer and targets MIB1.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

  4. ZHAO J, Li Q, Feng B, Wei D, et al
    MicroRNA149 inhibits cancer cell malignant phenotype by regulating Akt1 in C42 CRPC cell line.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

    November 2021
  5. SHENG W, Xu W, Ding J, Li L, et al
    Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR9.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

    September 2021
  6. DU W, Li D, Xie J, Tang P, et al
    miR3673p downregulates Rab23 expression and inhibits Hedgehog signaling resulting in the inhibition of the proliferation, migration, and invasion of prostate cancer cells.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

  7. LIN J, Chen Z, Li Z, Nong D, et al
    Screening of hub genes and evaluation of the growth regulatory role of CD44 in metastatic prostate cancer.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

    August 2021
  8. TORRES MJ, Lopez-Moncada F, Herrera D, Indo S, et al
    Endothelin-1 induces changes in the expression levels of steroidogenic enzymes and increases androgen receptor and testosterone production in the PC3 prostate cancer cell line.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

    July 2021
  9. LI JM, Lee S, Zafar R, Shin E, et al
    Sodium bicarbonate transporter NBCe1 regulates proliferation and viability of human prostate cancer cells LNCaP and PC3.
    Oncol Rep. 2021;46.
    PubMed     Abstract available

    May 2021
  10. PEREZ G, Lopez-Moncada F, Indo S, Torres MJ, et al
    Knockdown of ZEB1 reverses cancer stem cell properties in prostate cancer cells.
    Oncol Rep. 2021;45.
    PubMed     Abstract available

    April 2021
  11. YANG Y, Liu T, Hu C, Xia H, et al
    Ferroptosis inducer erastin downregulates androgen receptor and its splice variants in castrationresistant prostate cancer.
    Oncol Rep. 2021;45:1.
    PubMed     Abstract available

    March 2021
  12. ZHU J, Qin P, Cao C, Dai G, et al
    Use of miR145 and testicular nuclear receptor 4 inhibition to reduce chemoresistance to docetaxel in prostate cancer.
    Oncol Rep. 2021;45:963-974.
    PubMed     Abstract available

  13. JI J, Shen T, Li Y, Liu Y, et al
    CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
    Oncol Rep. 2021;45:921-932.
    PubMed     Abstract available

    December 2020
  14. XIE H, Zhao J, Wan J, Zhao J, et al
    Long noncoding RNA AC245100.4 promotes prostate cancer tumorigenesis via the microRNA1455p/RBBP5 axis.
    Oncol Rep. 2020 Dec 10. doi: 10.3892/or.2020.7894.
    PubMed     Abstract available

    November 2020
  15. NOGUCHI M, Fujimoto K, Arai G, Uemura H, et al
    A randomized phase III trial of personalized peptide vaccination for castrationresistant prostate cancer progressing after docetaxel.
    Oncol Rep. 2020 Nov 11. doi: 10.3892/or.2020.7847.
    PubMed     Abstract available

  16. HE G, Li M, Fang L, Xu L, et al
    NMyc induces the tumor progression of prostate cancer by regulating FSCN1.
    Oncol Rep. 2020;44:2265-2274.
    PubMed     Abstract available

    October 2020
  17. SHIMIZU K, Matsumoto H, Hirata H, Ueno K, et al
    ARHGAP29 expression may be a novel prognostic factor of cell proliferation and invasion in prostate cancer.
    Oncol Rep. 2020 Oct 15. doi: 10.3892/or.2020.7811.
    PubMed     Abstract available

  18. XU X, Zhu Z, Xu Y, Tian S, et al
    Effects of zinc finger protein 403 on the proliferation, migration and invasion abilities of prostate cancer cells.
    Oncol Rep. 2020 Oct 1. doi: 10.3892/or.2020.7786.
    PubMed     Abstract available

    September 2020
  19. BAI S, Chen T, Yu X, Luo M, et al
    [Corrigendum] The specific killing effect of matrine on castrationresistant prostate cancer cells by targeting the Akt/FoxO3a signaling pathway.
    Oncol Rep. 2020 Sep 29. doi: 10.3892/or.2020.7784.
    PubMed     Abstract available

  20. HUO W, Qi F, Wang K
    Long noncoding RNA BCYRN1 promotes prostate cancer progression via elevation of HDAC11.
    Oncol Rep. 2020;44:1233-1245.
    PubMed     Abstract available

  21. WANG F, Wang W, Lu L, Xie Y, et al
    MicroRNA165p regulates cell survival, cell cycle and apoptosis by targeting AKT3 in prostate cancer cells.
    Oncol Rep. 2020;44:1282-1292.
    PubMed     Abstract available

    MDM2 as a target for ellagic acidmediated suppression of prostate cancer cells in vitro.
    Oncol Rep. 2020;44:1255-1265.
    PubMed     Abstract available

    August 2020
  23. WANG H, Huang W, Yu X, Li W, et al
    [Corrigendum] Two prostate cancerassociated polymorphisms in the 3'UTR of IGF1R influences prostate cancer susceptibility by affecting miRNA binding.
    Oncol Rep. 2020;44:786.
    PubMed     Abstract available

    July 2020
  24. LING XH, Fu H, Chen ZY, Lu JM, et al
    [Corrigendum] miR505 suppresses prostate cancer progression by targeting NRCAM.
    Oncol Rep. 2020 Jul 17. doi: 10.3892/or.2020.7696.
    PubMed     Abstract available

    June 2020
  25. WANG Y, Pei X, Xu P, Tan Z, et al
    E2F7, regulated by miR30c, inhibits apoptosis and promotes cell cycle of prostate cancer cells.
    Oncol Rep. 2020 Jun 24. doi: 10.3892/or.2020.7659.
    PubMed     Abstract available

    May 2020
  26. LIN M, Bu C, He Q, Gu J, et al
    TAZ is overexpressed in prostate cancers and regulates the proliferation, migration and apoptosis of prostate cancer PC3 cells.
    Oncol Rep. 2020 May 19. doi: 10.3892/or.2020.7616.
    PubMed     Abstract available

    February 2020
  27. JIANG G, Liang X, Huang Y, Lan Z, et al
    p62 promotes proliferation, apoptosisresistance and invasion of prostate cancer cells through the Keap1/Nrf2/ARE axis.
    Oncol Rep. 2020 Feb 28. doi: 10.3892/or.2020.7527.
    PubMed     Abstract available

  28. PU J, Li T, Liu N, Luo C, et al
    PLCepsilon knockdown enhances the radiosensitivity of castrationresistant prostate cancer via the AR/PARP1/DNAPKcs axis.
    Oncol Rep. 2020 Feb 26. doi: 10.3892/or.2020.7520.
    PubMed     Abstract available

    December 2019
  29. LI W, Zhang J, Zou L, Cui J, et al
    Palmitoylome profiling indicates that androgens regulate the palmitoylation of alphatubulin in prostate cancerderived LNCaP cells and supernatants.
    Oncol Rep. 2019;42:2788-2796.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.